Trans-3-((tert-butoxycarbonyl)aMino)cyclopentanecarboxylicacid

98%

Reagent Code: #244353
fingerprint
CAS Number 1245614-69-0

science Other reagents with same CAS 1245614-69-0

blur_circular Chemical Specifications

scatter_plot Molecular Information
Weight 229.27 g/mol
Formula C₁₁H₁₉NO₄
badge Registry Numbers
MDL Number MFCD14279336
inventory_2 Storage & Handling
Storage Room temperature, seal, dry

description Product Description

Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of protease inhibitors and other bioactive molecules. Its structure allows for selective functionalization, making it valuable in medicinal chemistry for building chiral, constrained ring systems that enhance metabolic stability and binding affinity. Commonly employed in solid-phase and solution-phase peptide synthesis due to the presence of orthogonal protecting groups. Also utilized in the preparation of cyclopentane-based scaffolds for drug discovery research targeting viral infections and central nervous system disorders.

shopping_cart Available Sizes & Pricing

Size Availability Unit Price Quantity
inventory 100mg
10-20 days ฿8,070.00
inventory 250mg
10-20 days ฿16,120.00
inventory 500mg
10-20 days ฿26,860.00
inventory 1g
10-20 days ฿40,330.00
$product.analytical_desc - NULL

Cart

No products

Subtotal: 0.00
Total 0.00 THB
Trans-3-((tert-butoxycarbonyl)aMino)cyclopentanecarboxylicacid
No image available

Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of protease inhibitors and other bioactive molecules. Its structure allows for selective functionalization, making it valuable in medicinal chemistry for building chiral, constrained ring systems that enhance metabolic stability and binding affinity. Commonly employed in solid-phase and solution-phase peptide synthesis due to the presence of orthogonal protecting groups. Also utilized in the preparati

Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of protease inhibitors and other bioactive molecules. Its structure allows for selective functionalization, making it valuable in medicinal chemistry for building chiral, constrained ring systems that enhance metabolic stability and binding affinity. Commonly employed in solid-phase and solution-phase peptide synthesis due to the presence of orthogonal protecting groups. Also utilized in the preparation of cyclopentane-based scaffolds for drug discovery research targeting viral infections and central nervous system disorders.

Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Purchase History for

Loading purchase history...